9th Annual Biomarkers Congress

View Profile


Speaking/Presenting-Abstract/Poster at Mtg

Topic Authors / presenters Event name Event date
1. Soluble receptor proteins in control of gene expression Int. Meeting on Extrahepatic Drug Metabolism and Chemical Carcinogenesis, Stockholm, Sweden January, 2011
2. Hormones and Cancer PARE Research Conference, NIH, Bethesda, USA December, 2010
3. ERbeta – a new concept in estrogen signaling with exciting novel implications for cardiometabolic disease Gender and Myocardial Hypertrophy, Berlin, Germany November, 2010
4. Estrogen receptor beta and liver X receptor beta in disease” OMRF Research Forum, Oklahoma City, Oklahoma, USA October, 2010
5. Zebrafish as a model to study endocrine disruption e.hormone 2010, New Orleans, Louisiana, USA October, 2010
6. Estrogen receptor beta and liver X receptor beta – two exciting targets for drug development Dean’s Lecture, School of Basic Medical Sciences, Beijing University, Beijing, China October, 2010
7. Hormones and Cancer Third Military Medical University, Chongqing, China October, 2010
8. Estrogen receptor beta and liver X receptor beta – two exciting targets for drug development First Mini-Symposium of Chinese Nuclear Receptor Research Group (CNRRG), Chongqing, China October, 2010
9. The role of estrogen receptors in breast cancer Diczfalusy Symposium on Reproductive Health, Nobel Forum, Karolinska Institutet Stockholm September, 2010
10. Importance of Science Keynote Speaker at the Fall 2010 Convocation, The Honors College, The University of Houston September, 2010
11. Mechanism of estrogen action – new paradigms King Abdullah University of Science and Technology (KAUST), Jeddah, Saudi Arabia August, 2010
12. Hormones and Cancer The Methodist Hospital, Houston, USA July, 2010
13. Role of ERbeta and LXRbeta in proliferation MD Anderson Cancer Center, Endocrine Research Seminar, Houston, USA May, 2010
14. ERbeta and LXRbeta – Nuclear receptors of growing importance Baylor College of Medicine, Kroc Lecture, Houston, USA May, 2010
15. Estrogen receptor beta as an antiproliferative principle McArdle Institute for Cancer Research, Madison, WI, USA May, 2010
16. New Angles in Nuclear Receptor Research: ERbeta and LXRbeta Levey Symposium, University of California Los Angeles,USA May, 2010
17. Estrogen receptor beta as an antiproliferative principle Radiumhemmet, Karolinska University Hospital, Solna, Sweden April, 2010
18. Implications of estrogen signaling in cardiovascular medicine Cardiovascular Clinic, Karolinska University Hospital, Huddinge, Sweden April, 2010
19. Estrogen receptor beta – a potential target for anti-cancer drugs AAAS SWARM Division 85th Annual Meeting, Houston, USA April, 2010
20. Estrogen signaling and cancer UH Cancer Research Forum, Houston, USA April, 2010
21. Novel Biological Roles of LXRs Keystone Symposium on Nuclear Receptors: Signaling, Gene Regulation and Cancer, Colorado, USA March, 2010
22. The New Biology of Estrogen Signaling College of Biological Sciences, UC Davis, California, USA February, 2010
23. Nuclear receptors and Cancer Department of Molecular&Cellular Oncology andCenter for Biological Pathways,MD Anderson Cancer Center, Houston, Texas, USA January, 2010
24. Roles of nuclear receptors ER beta and LXR beta in cellular proliferation GI Cancer Research Seminar Series – MD Anderson Cancer Center, Houston, Texas, USA January, 2010
25. The Science of Endocrine Disruptors and Relevance to Human Health Dietary Exposure to Endocrine-Active Pesticides”, Brussels, Belgium November, 2009
26. Paradigm shifts in understanding estrogen signaling The University of Texas Health Science Center, Houston, Texas, USA November, 2009
27. Nuclear receptors – Potential targets for environmental pollutants 2009 North American Hazardous Materials Management Association Conference, Houston, USA. Keynote lecture November, 2009
28. Research as a lifestyle – Joy and happiness The University of Texas, MD Anderson Cancer Center, Provost’s Career Builders Series, Houston, USA November, 2009
29. The influence of estrogen receptor beta in breast cancer The Methodist Hospital Research Institute, Breast Medical Oncology Research Meeting, Houston, USA October, 2009
30. Estrogen receptor beta and hormonally active chemicals e.hormone 2009, New Orleans, USA October, 2009
31. Estrogen signaling via estrogen receptor beta Cincinnati Cancer Symposium Series, Jensen Symposium on Nuclear Receptors, Cincinnati, USA October, 2009
32. Novel Aspects of LXR action EMBO Conference on Nuclear Receptors, Cavtat/Dubrovnik, Croatia September, 2009
33. Estrogen receptor beta and cancer Spetses Summer School on Nuclear Receptor Signalling: From Molecular Mechanisms to Integrative Physiology, Island of Spetses, Greece August, 2009
34. Nuclear receptors and cancer The Saitama Medical School, Saitama, Japan July, 2009
35. Nuclear receptors and cancer The University of Sapporo, Sapporo, Japan July, 2009
36. Nuclear receptors and cancer The National Cancer Research Center Institute, Tokyo, Japan July, 2009
37. Hormones and Cancer The Methodist Hospital, Houston, Texas, USA June, 2009
38. Molecular mechanisms involved in exposures to estrogenic and anti-estrogenic endocrine disruptors 5th Copenhagen Workshop on Endocrine Disrupters, Copenhagen, Denmark May, 2009
39. Geoffrey Harris Prize Lecture, “The new biology of estrogen signaling 11th European Congress of Endocrinology, Istanbul, Turkey April, 2009
40. Plenary opening lecture, “Clinical implications of the new biology of estrogen action 43rd Annual Scientific meeting of the European Society for Clinical Investigation, Franfurt/Main, Germany April, 2009
41. Plenary lecture, “Estrogen receptor beta as a potential target in the treatment of prostatic cancer First Serbian Congress of Endocrinology, Belgrade, Serbia December, 2008
42. Estrogen receptor beta as a potential target in treating aging males and females Menopause, Andropause, Anti-Aging, Vienna, Austria December, 2008
43. New concepts in estrogen signaling National Cancer Center Research Institute, Tokyo, Japan November, 2008
44. Estrogen receptors Symposium on Sex Steroids, Gothenburg, Sweden November, 2008
45. Estrogen-receptors: A short overview Round Table Meeting of the Senate Commission on Food Safety of the German Research Foundation (DFG), Phytoestrogens in food supplements and dietary foods for special medical purposes, Bonn, Germany November, 2008
46. The tumor suppressor activity of estrogen receptor beta-implications for cancer prevention The Thirty-ninth International Symposium of The Princess Takamatsu Cancer Research Fund, Metabolic Syndrome: Carcinogenesis and Prevention, Tokyo, Japan November, 2008
47. Estrogen signaling in the lung” and “HRT and depression The 3rd International Congress of Gender Medicine, Stockholm, Sweden September, 2008
48. Interplay between ERa and ERb in estrogen signaling 13th International Congress on Hormonal Steroids and Hormones & Cancer, Quebec, Canada September, 2008
49. Antiproliferative actions of estrogen receptor beta University of Houston, Houston, USA September, 2008
50. The new biology of estrogen signaling Nobel Conference on “Recent advances in understanding estrogen signaling: From molecular insights to clinical implications”, Sånga-Säby, Stockholm, Sweden: September, 2008
51. Plant derived ligands of nuclear receptors and their biological effects 7th Joint Meeting of AFERP, ASP, GA, PSE & SIF, Natural products with pharmaceutical nutraceutical, cosmetic and agrochemical interest, Athens, Greece August, 2008
52. New biology of estrogen action Murikka Minisymposium 2008, Cell signaling and its transcriptional readout, Murikka, Finland August, 2008
53. ER-beta biology – Role in Genito-urinary and reproductive systems in men Estrogen Receptor-beta – Benign Prostatic Hyperplasia, Washington, USA July, 2008
54. Cancer and steroid receptors – state of the art XVI Symposium of the International Association on Gnotobiology – Joint with the XXXI Congress of the Society of Microbial Ecology and Disease, Djurönäset, Stockholm, Sweden May, 2008
55. Estrogen signaling and the metabolic syndrome Diabetes Research Center, Free University Brussels, Brussels, Belgium May, 2008
56. Nuclear receptors as drug targets in metabolic diseases Workshop on Pre-receptor steroid metabolism as target for pharmaceutical treatment, Eibsee, München, Germany May, 2008
57. New Developments in Biology and Mechanisms of Action of ERbeta” 7th Annual Symposium on the Environment and Hormones, e.hormone 2008, New Orleans, USA April, 2008
58. Antiproliferative actions of estrogen receptor beta – possible implications for LAM The LAM Foundation/NHLBI Lymphangioleiomyomatosis, Int. Research Conference, Cincinnati, USA April, 2008
59. Chairman 11th Frontiers in Nuclear Receptor Action, Savannah, Atlanta, USA April, 2008
60. “Estrogen receptor beta – a potential new target for treatment of breast and prostate cancer Novel Targeted Cancer Therapies: from Cells and Mice to Patients: Stockholm, Sweden March, 2008
61. Anti-proliferative action of estrogen receptor beta China-Sweden Workshop on Cancer Treatment and Research, Tianjin, China March, 2008
62. Estrogen receptors The 3rd Sino-Swedish Cancer Workshop, Guangzhou and Hainan, China March, 2008
63. Debate “Importance of membrane steroid receptors”. For: Carol Lange, Ph.D., Univ. of Minnesota, Minneapolis, MN, USA. Against: Jan-Åke Gustafsson, M.D., Ph.D. 55th Annual Meeting of the Society for Gynecologic Investigation, San Diego, USA March, 2008
64. Estrogen Receptor-Beta and Reproduction 55th Annual Meeting of the Society for Gynecologic Investigation, San Diego, USA March, 2008
65. The new biology of estrogen signaling Beijing Normal University, Beijing, China, March, 2008
66. Keynote lecture: “Effects of perturbed estrogen signaling on reproductive function Serono Symposia International Foundation, “Gene, environment, lifestyle interaction and human reproduciton, Malmö, Sweden February, 2008
67. Research and Innovation, Washington DC, USA Speaker at the Opening Seminar Sweden – The Best Health Care System in the World?, Health Care Innovation Week, Swedish Health Care February, 2008
68. Gender differences in targeting nuclear receptor signalling Milan University, Milan, Italy January, 2008
69. New developments in biology and mechanisms of action of ERbeta 33rd FEBS Congress & 11th IUBMB Conference, Biochemistry of Cell Regulation, Athens, Greece January, 2008
70. The different impact of various estrogenic receptors Menopause, andropause, anti-aging 2007, Vienna, Austria December, 2007
71. LXR and the CNS – possible connections to the ALS-Parkinsonism dementia complex?”. Saitama Medical University, Tokyo, Japan November, 2007
72. Current challenges in the understanding and management of colon cancer: “Estrogen receptor b and colon cancer The thirty-eighth International Symposium of The Princess Takamatsu Cancer Research Fund, Tokyo, Japan November, 2007
73. Inaugural Diabetes and Metabolic Disease Guest Lecture: “A new paradigm for signal transduction: Estrogen receptor beta signaling Methodist Hospital Research Institute, Houston, Texas October, 2007
74. Estrogen receptor beta is antiproliferative in breast cancer Brystkreft i fokus, Oslo, Norway October, 2007
75. New paradigms in estrogen action give new pharmaceutical opportunities for women’s health Biomedicum Helsinki Seminar Series, Helsinki, Finland October, 2007
76. Novel paradigms in estrogen signaling Charité – Universitätsmedizin Berlin, Center for Cardiovascular Research, Berlin, Germany September, 2007
77. Medical benefit from biologically active compounds in foods. Phytosteroids The Royal Swedish Academy of Sciences: Remedies from animals and plants, Stockholm, Sweden September, 2007
78. Targeting estrogen receptor beta offers new pharmaceutical opportunities – basic and applied aspects Women’s Mental Health Symposium: A New University of Miami Initative, University of Miami, Miami, USA August, 2007
79. Estrogen Receptors and the Metabolic Syndrome Eli Lilly, Indianapolis, USA July, 2007
80. An Update on Estrogen Signaling University of Cincinatti, Cincinatti, USA July, 2007
81. Update on Estrogen Receptor Beta Signaling Tufts-New England Medical Center, Boston, USA July, 2007
82. The role of estrogen signaling in the metabolic syndrome 21st Annual Therapeutic Options for Menopausal Health Conference, Pasadena, USA July, 2007
83. Biology of estrogen receptor b Genome Institute of Singapore July, 2007
84. Estrogens and depression 27th International Epilepsy Congress, Singapore July, 2007
85. New aspects in estrogen signaling Third Military Medical University, Chongqing, China July, 2007
86. Estrogen receptor b - a new paradigm in estrogen signaling Beijing Normal University, Beijing, China July, 2007
87. Liver X Receptor beta in the CNS 6th Dutch Endo-Neuro-Psycho Meeting, Doorwerth, the Netherlands June, 2007
88. A new era in devlopment of estrogenic pharmaceuticals: Alfa-estrogenic and beta-estrogenic drugs 10th Conference in Advanced Medicinal Chemistry, Thessaloniki, Greece May, 2007
89. Estrogen signaling in the brain and gu Digestive Disease Week 2007, Washington, USA May, 2007
90. LXRbeta – A link between beta-sitosterol and ALS-Parkinson’s dementia Nuclear Receptors: Stucture and Function in Health and Disease, Gardone Riviera, Lake Garda, Italy May, 2007
91. Estrogen receptor beta – a revolutionary in estrogen signaling University Hospital UZ Gasthuisberg, Leuven, Belgium May, 2007
92. New roles for estrogen receptor b in the developing and adult CNS 10th Frontiers in Nuclear Receptor Action, Georgia, USA: April, 2007
93. CASCADE past and future CASCADE 3rd Annual Meeting, Helsinki, Finland April, 2007
94. Role of estrogen signaling in the metabolic syndrome Keystone Symposia, Nuclear Receptor Pathways to Metabolic Regulation, Sheraton Steamboat Resort, Steamboat Springs, Colorado, USA March, 2007
95. The estrogen receptor beta Working session on Hormonoresistance in breast cancer, Paris, France March, 2007
96. Estrogen receptors in development Society for Endocrinology BES 2007, Birmingham, UK March, 2007
97. Dramatic changes in understanding of estrogen action Annual Meeting of the Swedish Society for Study of Reproduction, SSSR, Uppsala, Sweden March, 2007
98. Estrogen receptor beta – a novel antiproliferative transcription factor Global LAM Summit, Stockholm, Sweden February, 2007
99. Recent developments in nuclear receptor action 9th European Congress of Endocrinology, Budapest, Hungary January, 2007
100. An update of ER signaling” and LXR signalling in the central nervous system Spetses Summer School on Nuclear Receptor Signalling: From Molecular Mechanisms to Integrative Physiology, Island of Spetses, Greece January, 2007
101. The role of ERalpha and beta in endocrine disruptors toxicity International Conference on Food Contaminants and Neurodevelopmental disorders, Valencia, Spain December, 2006
102. Diet and genes Jilin University, Shool of Public Health, Changchun, China November, 2006
103. Estrogen receptor b - a multifunctional receptor and a promising drug target The National Cancer Center Research Institute, Tokyo, Japan November, 2006
104. Novel paradigms in estrogen signaling in health and disease The 10th Meeting Hirosaki International Forum of Medical Science, Hirosaki, Japan November, 2006
105. Novel actions of estrogen via estrogen receptor beta Duodecim Symposium on Nuclear receptors in health and disease, Turku, Finland November, 2006
106. Novel paradigms in estrogen signaling in health and disease Jilin University, Department of Pathology, Changchun, China October, 2006
107. Honorary Lecture “Estrogen receptor beta – a new paradigm in estrogen signaling 3rd International Greek Biotechnology Forum, Athens, Greece October, 2006
108. Paradigm shifts in our understanding of estrogen signaling following the discovery of estrogen receptor beta Founding Symposium, International Graduate School in Molecular Medicine Ulm, Ulm, Germany October, 2006
109. Role of estrogen receptor b (ERb) and liver X receptor b (LXRb) in the central nervous system Nuclear Receptors 2006 - An International Symposium arranged by the Center for Biosciences, Karolinska Institutet, Huddinge, Sweden September, 2006
110. New paradigms in estrogen signaling rapidly translate into clinical medicine The Institute of Cancer Research, Breakthrough Breast Cancer Research Centre, London, U.K September, 2006
111. Regulation of prostate growth by estrogen receptors a and b 12th International Congress on Hormonal Steroids and Hormones & Cancer, Athens, Greece September, 2006
112. The estrogen receptor and cardiovascular diseases 11th Annual Meeting of the European Council for Cardiovascular Research (ECCR), La Colle sur Loup, Nice, France September, 2006
113. Nuclear receptors in disease AP ECHO, Asia-Pacific Education Center of Hematology/Oncology and Translational Medicine, Shanghai, China August, 2006
114. Plenary Lecture: “Recent Highlights in Estrogen Signaling Bregenz Summer School on Endocrinology: Nuclear Receptors in Health & Disease, Bregenz, Austria August, 2006
115. Recent advances in estrogen-signaling and new sites for pharmacological interventions 15th World Congress of Pharmacology, Beijing, China July, 2006
116. Estrogen receptor b - a new drug target Academy of Military Medical Sciences (AMMS), Beijing, China July, 2006
117. New discoveries in estrogen signaling translate into clinical medicine Second Military Medical University, Shanghai, China July, 2006
118. New developments in oestrogen signalling BioScience 2006, Glasgow, UK July, 2006
119. Estrogen action – two different signaling pathways Symposium “Neue Erkenntnisse in der Frauenhelikunde – Gesundheit, Hormone und Soja”, Vienna, Austria June, 2006
120. Steroid receptors, crosstalk and potential endocrine disruption” 5th Gordon Research Conference on Environmental Endocrine Disruptors, Il Ciocco, Barga, Italy June, 2006
121. Recent advances in estrogen signaling 132nd Advanced Course on : Estrogens and Human Diseases, Erice, Italy May, 2006
122. ERbeta scientific visions translate to clinical uses Yale University School of Medicine, OB GYN Seminar Series, New Haven, USA May, 2006
123. Nuclear receptor signaling – a gold mine for development/application of novel techniques for studies on molecular interactions EUROPT(R)ODE VIII, Tübingen, Germany April, 2006
124. Liver X receptor 41st Annual meeting of The European Association for the study of the liver, Vienna, Austria April, 2006
125. chairman 9th Frontiers in Nuclear Receptor Action, Sanibel Harbour, Ft Myers, Florida April, 2006
126. CASCADE – past and future CASCADE 2nd Annual Meeting, St Malo, France March, 2006
127. Plenary lecture, “Clinical use of estrogen receptor beta European Society for Clinical Investigation, 40th Annual Scientific Meeting, Prague, Czech Republic March, 2006
128. Biology of estrogen receptor b - New insights Keystone Symposia, Nuclear Receptors: Orphan Brothers, Banff, Alberta, Canada March, 2006
129. Estrogen receptors in the brain The 1st World Congress on Gender-Specific Medicine, “Men, Women, and Medicine: A New View of the Biology of Sex/Gender Differences and Aging”, Berlin, Germany February, 2006
130. Role of estrogen receptor beta in reproduction Keystone Symposia, Reproduction: Advances and Challenges, Santa Fe, New Mexico, USA February, 2006
131. A new look at estrogen signaling Yale University School of Medicine, Pharmacology Seminar Series, New York, USA January, 2006
132. The aromatase KO mouse – an appropriate model for menopause? Second meeting of the project estrogen in women ageing (EWA), Madrid, Spain January, 2006
133. ER b - a multifunctional nuclear receptor 5th Int. Congress of Pathophysiology, Beijing, China January, 2006
134. Erbeta and menopause University of Milan, EWA – Estrogens and Women Aging, Milano, Italy January, 2006
135. A new look on estrogen signaling: The role of estrogen receptor  University of Kentucky, Lexington, USA January, 2006
136. On the role of estrogen receptor b in the immune system The MTC Annual Talks 2005, Nobel Forum, KI, Stockholm, Sweden November, 2005
137. Estrogen receptor b in breast cancer China TEDA Bioforum, Advances in Life Sciences, Tianjin, China November, 2005
138. New surprises in estrogen signalling Int. symp. Endocrine disrupters – Occurrence in the bioenvironment and possible effects in animals and humans, Oslo, Norway October, 2005
139. Estrogen receptor beta in breast cancer 1 Simpósio Mulher Sempre Mulher, Hormones and Breast Estrogen Receptor Beta and SERM’s, Lisbon, Portugal October, 2005
140. The role of LXR in the liver, adipocytes and nervous system 46th International Conference on the Bioscience of Lipids, Ajaccio, Corsica September, 2005
141. Estrogen receptor beta – a new paradigm in estrogen signaling Center for Molecular Medicine, University of Cologne, Cologne, Germany September, 2005
142. Mechanisms of action of female sex hormones Int. Workshop on Physical Sciences at the Microscale and First IAAC meeting of HFNL, Hefei and Huang shan, China August, 2005
143. Hormone-disrupting chemicals – what are they?”. CASCADE Open Forum, The chemical pollutants in our food, Visby, Sweden July, 2005
144. ERb - a multifunctional regulator Eli Lilly, Indianapolis July, 2005
145. Antiproliferative actions of Erbeta – mechanisms and possible pharmaceutical applications Hormone Action in Development & Cancer, Gordon Research Conference, Mount Holyoke, South Hadley, USA July, 2005
146. Pathfinder – a Euorpean network for research on nuclear receptors Descartes Prize Nominee Meeting, Brussels July, 2005
147. Keynote lecture “Recent excitements in drug development based on novel insights in estrogen signalling Engebretson symposium on drug discovery and development in cancer experimental therapeutics, Minnesota, USA June, 2005
148. Estrogen receptor beta ENDO 2005, San Diego, USA June, 2005
149. ERin normal and malignant breast The Third International Symposium on the Molecular Biology of Breast Cancer, Molde, Norway June, 2005
150. Estrogen receptor : an antiproliferative principle in the prostate 8th Int. Congress of Andrology and 22nd Annual Meeting of Korean Andrological Society, Men’s health – nature and nurture, Seoul, Korea June, 2005
151. Keynote Lecture “Estrogen receptor b - a novel tumor suppressor gene? 62nd KSBMB Annual Meeting in 2005 – From mechanism to functions, Seoul, South Korea May, 2005
152. ERbeta and CNS function Nobel minisymposium “Sex differences in the human brain, their mechanisms and implications”, Stockholm, Sweden May, 2005
153. Estrogen receptor  as novel target for antiproliferative drugs 40th Anniversary of the IARC, Lyon, France May, 2005
154. Lessons learnt from ERbeta and LXRbeta KO mice The fifth annual meeting of the Network for functional studies in mice, Stockholm, Sweden May, 2005
155. Precocious puberty and early ovarian failure in CYP7B1 knockout mice 6th Puberty Conference, Evian, France May, 2005
156. Estrogen signaling – New mechanisms 8th Frontiers in Nuclear Receptor, Phoenix, Arizona, USA April, 2005
157. Estrogen receptor beta – a multifunctional regulator 2nd Ernst Knobil Memorial Lecture, San Diego, USA April, 2005
158. Nuclear receptors during two centuries Keynote Lecture at Symposium in the honor of Dr. Paul van der Saag, Utrecht, The Netherlands March, 2005
159. Antiproliferative actions of ERb Keystone symposia on Hormonal Regulation of Tumorgenesis, Monterey, California, USA February, 2005
160. Integration of international organisations in CASCADE network of excellence: Chemicals as contaminants in the food chain: a network of excellence for research, risk assessment, education and information Enhanced International Collaboration in the Field of Endocrine Disrupters: How to do it in practice? Workshop Organised by the European Commission’s Research Directorate-General, Brussels, Belgium January, 2005
161. Estrogen receptors and breast cancer Fourth Annual AACR Int. Conf., Frontiers in Cancer Prevention Research, Baltimore, USA January, 2005
162. ERbeta – an antiproliferative principle EMBO Conference, Nuclear Receptor: From Chromatin to Disease, Lake Garda, Italy January, 2005
163. Nuclear receptors – an overview Cascade 1st Annual Meeting, Chemical Contaminants in Food: Proposals for Scientific Research, Orvieto, Italy January, 2005
164. New excitements in estrogen signalling China University of Science & Technology, Hefei, China December, 2004
165. Estrogen signalling in the CNS Institute of Neuroscience, Chinese Academy of Sciences, Shanghai, China December, 2004
166. Steroids and ageing DG RTD Workshop: Mechanisms of organ specific ageing, Brussels, Belgium December, 2004
167. Novel concepts in estrogen signaling open up new therapeutical possibilities in many areas Tokyo University, Inst. of Molecular and Cellular Biosciences, Japan November, 2004
168. A new look at estrogen signaling Nuclear Receptors and Genomic Medicine, Saitama Medical School, Saitama, Japan November, 2004
169. ERb and cancer National Cancer Center Research Institute, Tokyo, Japan November, 2004
170. Nuclear Receptors, A rapidly developing field China TEDA Bioforum, Tjianjin, China October, 2004
171. Estrogen signaling in new light Nuclear Receptors 2004 - An International Symposium arranged by the Center for Biotechnology (CBT), Karolinska Institutet, Huddinge, Sweden October, 2004
172. New surprises in estrogen signaling e.hormone 2004, Tulane University, New Orleans, USA October, 2004
173. New paradigms in estrogen signalling Annual Bristol-Myers Squibb/Mead Johnson Nutrition Award Symposium, New York, USA October, 2004
174. LXR and ER signaling CASCADE Summer School on Nuclear Receptors, ENS Lyon, Lyon, France September, 2004
175. Estrogen receptor ESPE 18th Summer School 2004, “Estrogen receptor”, Ramsach, Switzerland September, 2004
176. Estrogen signaling in the mammary gland 55th Annual Meeting of the European Association for Animal Production, Bled, Slovenien September, 2004
177. New paradigms in estrogen signaling and their clinical implications 43rd Annual Meeting of the European Society for Pediatric Endocrinology, Basel, Switzerland September, 2004
178. Estrogen derivatives in cardiovascular disease-old questions, new answers; “New paradigms in estrogen signaling with particular reference to cardiovascular function XVIII World Congress International Society for Heart Research, Brisbane, Australia August, 2004
179. New vistas in estrogen signaling: Therapeutical implications UT Forum 2004 in Sweden, Medical and Life Sciences, “Molecular Medicine and Its Recent Advances”, Stockholm, Sweden August, 2004
180. Recent excitements in drug development based on novel insights in estrogen signaling XVIIIth International Symposium on Medicinal Chemistry, Copenhagen, Denmark August, 2004
181. Targeting cancers by estrogens and its analogs 37th Annual Meeting of the Society for the study of reproduction, Vancouver, British Columbia, Canada August, 2004
182. The role of the estrogen receptor b in neuroprotection Seventh International Symposium on Neurobiology and Neuroendocrinology of Aging, Bregenz, Austria July, 2004
183. Role of P450 in steroid hormone action MDO 2004, 15th International Symposium on Microsomes and Drug Oxidations: Chemical biology in the postgenomic era; new approaches and applications, Mainz, Germany July, 2004
184. Projet CE: CASCADE Workshop “Food safety and quality: state of research in the Southern Mediterranean Agronomic Studies”, Bari, Italy July, 2004
185. ERb and immunology Summer School on Endocrinology, Nuclear Receptors, Endocrine Disruptors and Metabolic Effects, Bregenz, Austria July, 2004
186. Nuclear receptors as signal sensors Environmental and Endocrine Signaling, A Satellite Symposium preceding the annual Society of Endocrinology Meeting, New Orleans, USA June, 2004
187. Recent excitements in estrogen signaling Eli Lilly, Indianapolis, Illinois, USA June, 2004
188. New vistas in estrogen signaling Breast Cancer Meeting, New Orleans, USA June, 2004
189. A new look at estrogen signaling Nuclear receptors, transcription, and cancer symposium, University of Virginia, Virginia, USA May, 2004
190. Estrogen receptor beta regulates epithelial cell differentiation in the mouse ventral prostate 15th Symposium on Growth Hormone and Endocrinology, Malta April, 2004
191. Estrogen signaling and the cardiovascular system – some new angles European Atherosclerosis Society, 74th EAS Congress, Seville, Spain April, 2004
192. On the role of estrogen receptors and liver X receptors in lipid metabolism 55. Mosbacher Kolloquium: How nutrients influence gene activity, Mosbach, Baden, Germany April, 2004
193. Estrogen signaling and the immune system – new excitements Hormones and the Genome, HLSC 3rd event, Endocrine malignancies and autoimmunity, Molecular biological events and targets for clinical application, Ulm, Germany April, 2004
194. ERb - A multifunctional regulator of women’s health 5th International Symposium on Women’s Health and Menopause, Florence, Italy April, 2004
195. Estrogen signaling – an area of rapid development and relevance Umeå University March, 2004
196. New roles of estrogen receptor b Keystone Symposia on Nuclear Receptors: Orphan Brothers, Keystone Resort, Colorado: February, 2004
197. Novel functions of estrogen receptor beta Updates in Infertility Treatment, Marco Island, Florida, USA January, 2004
198. New paradigms in estrogen signaling open up novel pharmaceutical approaches for several diseases Biomedicum Helsinki, Helsinki, Finland January, 2004
199. : Keynote lecture “Estrogen signaling and cancer prevention Inaugural COST 926 Conf. Eur. Workshop on Cellular Responses to bioactive plant compounds – implications for human health, Budapest, Hungary January, 2004
200. Effects of ERb on the CNS ERPM 2004, Stéroïdes sexuels: le point sur l’action des estrogènes et des progestatifs. Montpellier, France January, 2004
201. A new look upon estrogen signaling A. I. Virtanen Institute Research Seminars, Kuopio, Finland January, 2004
202. Estrogen receptor-beta – a multifunctional transcription factor Workshop Nuclear Receptors, Leiden, Netherlands January, 2004
203. Academy-industry interactions at the Novum Campus in Stockholm Boosting Innovation from Research to Market, Bryssel, Belgium December, 2003
204. Yin-yang of estrogen signaling Rui Jin Hospital, Shanghai, China December, 2003
205. Nuclear Receptors – From Academia to Commercial Application The Biotechnology, the Capital and the Brain – The Mixing Chemistry of Bioeconomy, Beijing, China December, 2003
206. Estrogens and diseases of brain and the immune system Jensen Symposium, Nuclear Receptors and Endocrine Disorders, Cincinnati, USA December, 2003
207. “Metabolism Bengt E Gustafsson Symposium, Microbial Ecology in Health & Disease, Born germfree – microbial dependent, Stockholm November, 2003
208. ERbeta in the nervous system The 6th U.S.- Taiwan Neuroscience Symposium, Estrogen actions in the brain, New Orleans, USA November, 2003
209. New paradigms of estrogen signalling – genderaspects The 2nd International Symposium of Gender Related Medicine at Centre of Gender Related Medicine, Karolinska Institutet, Stockholm, Sweden October, 2003
210. Estrogen signaling – a case of yin and yang 13th Annual Meeting of the Dutch Society for Calcium and Bone Metabolism, Zeist, The Netherlands October, 2003
211. Novel views on estrogen signaling Eleventh Annual Nuclear Receptor Symposium, Nuclear Receptors: Discovery, Biology, and Therapy, Stevenage, U.K October, 2003
212. Estrogen Receptor Beta in Development and Cancer”. International School of Medical Science, 117th Advanced Course on Signal Transduction and Communication in Cancer Cells, Erice, Italy October, 2003
213. “Steroid receptors” and “Specific alpha and beta ER-ligands”. Maturitas Master Class, Lisbon, Portugal October, 2003
214. Estrogens and the Immune System: Novel Lessons from ERalfa and ERbeta KO Mice The Endocrine Society: The Role of Nuclear Receptors in Cardiovascular Disease, San Diego October, 2003
215. New views on estrogen signaling Lecture at the University of Mainz, Institute of Toxicology, Mainz, Germany September, 2003
216. Mechanisms of estrogen action” and “Insight into the biology of estrogen and Liver X receptors by studying knock-out mice FEBS Advanced Study Institute, International Summer School, From transcription to physiology: Regulation of gene expression and protein function in an integrated context, Spetses, Greece September, 2003
217. New understanding of estrogen action Rudbeck seminars, Uppsala University September, 2003
218. Development and an overview of ERb 8th Nottingham International Breast Cancer Conference, Nottingham, U.K September, 2003
219. LXR and control of lipid homeostasis Nobel Conference No 40, Transcriptional control of lipid homeostasis, Stockholm, Sweden August, 2003
220. Some phenotypes of LXR KO mice HLSC 2nd event, Hormones and Genome, Molecular Mechanisms in Metabolic Diseases: Obesity, Diabetes Type 2, Lipid disorders and Atherosclerosis – Basic Science towards Clinical Application, Ulm, Germany July, 2003
221. Estrogen receptors and metabolic syndrome Summer School on Endocrinology, Bregenz, Austria July, 2003
222. Some phenotypes of LXR KO mice 19th Ernst Klenk Symposium, Transcriptional and other regulatory mechanisms of lipid metabolism, Cologne, Germany July, 2003
223. Datta Lecture “Update on estrogen signaling Special FEBS 2003 Meeting on Signal Transduction; Signal transduction: from membrane to gene expression, from structure to disease, Brussels, Belgium July, 2003
224. New paradigms in estrogen signaling Utrecht Graduate School of Developmental Biology, Utrecht, The Netherlands June, 2003
225. A novel mechanism for control of prostate growth Fourth International Symposium on Hormonal Carcinogenesis, Valencia, Spain: June, 2003
226. Oestrogen signaling and cancer European Code against cancer, Clinical Cancer Research in Europe, Milan, Italy: June, 2003
227. Estrogen signaling – importance of conformational changes in estrogen receptor action Allosteric Mechanisms of Signal Transduction, Paris, France June, 2003
228. Estrogen receptor-beta – A paradigm shift in understanding estrogen signaling Special Symposium on estrogen receptors, Los Angeles, USA June, 2003
229. Antiproliferative actions of estrogen receptor b”. EMBO Conference, Biology of Nuclear Receptors, Villefranche-sur-Mer (Nice), France June, 2003
230. Marius Tausk Lecture, “New paradigms in estrogen signaling 2nd Dutch Endo-Neuro-Psycho meeting, Doorwerth, The Netherlands June, 2003
231. Elucidation of ERb function in breast cancer Novel approaches to treatment in hormone-sensitive breast cancer, London, U.K May, 2003
232. Plenary Lecture, “Modulation of estrogen action by ER isoforms Calcified Tissue International, Rome, Italy May, 2003
233. Chairman at the 7th Annual Frontiers in Estrogen Action The Homestead, Hot Springs, Virginia April, 2003
234. Plenary Lecture, “Role of estrogen receptors: lessons from knock-out mice 6th European Congress of Endocrinology, Lyon, France: April, 2003
235. The academic research perspective On Target 2010: The Future of Medicines, Stockholm, Sweden April, 2003
236. Novel functions of ER as revealed by studies of phenotypes of ER K.O.-mice Ernst Schering Research Foundation, Workshop 46, New molecular mechanisms of estrogen action and their impact on future perspectives in estrogen therapy, Berlin, Germany March, 2003
237. Frontiers in nuclear receptors research International Group on Insulin Secretion, Novel Factors in the Regulation of b-cell function, St. Jean-Cap-Ferrat March, 2003
238. A new look on estrogen signaling Distinguished Guest for 2003 in the Molecular and Cellular Biology Department at Baylor College of Medicine, Houston, Texas, U.S.A February, 2003
239. Estrogens – how do they work? Symposium Regulation of cell signalling by estrogens and phytoestrogens, McDowell Lecture in Physiology, London, U.K January, 2003
240. Oestrogen receptors British Pharmacological Society Wintermeeting, Nuclear receptors: targets for new therapies, Brighton, U.K January, 2003
241. A new paradigm in estrogen signaling provided by the dynamic interplay between ERalpha and ERbeta” Burroughs Wellcome Fund Visiting Professorship In the Basic Medical Sciences, University of Texas Medical Brand School of Medicine, Houston, Texas, USA November, 2002
242. The novel estrogen receptor beta – possible implications for breast cancer Fourth Amazon Project Conference, Innaovative Strategies and Perpectives in Cancer Care, Palermo, Italy November, 2002
243. Nuclear receptors and regulation of cholesterol homeostasis Biomedicum Helsinki Seminars: Frontiers in Medicine, Helsinki, Finland November, 2002
244. Estrogen receptors – from molecular biology ot therapeutics Women’s Health Special Interest Group (WHSIG), NIH; Washington, USA November, 2002
245. Recent advances in our understanding of nuclear receptor action Tianjin TEDA Watson Biopark Development Conference, Tianjin, China October, 2002
246. Environmental signals: Multiple receptors & multiple inputs e.hormone 2002, New Orleans, USA October, 2002
247. State of the Art Lecture, “New paradigms in understanding estrogen signaling International Society for the Study of Women’s Sexual Health, Annual Meeting 2002, Vancouver, Canada October, 2002
248. Mechanisms of endocrine signaling 30th Conference of the European Teratology Society in conjunction with the symposium Adverse effects of endocrine disruptors, Hannover, Germany September, 2002
249. A novel endocrine pathway in the prostate, ERb, AR, 5a -androstane-3b, 17b-diol, and CYP7B1, regulates prostate growth 2nd European Congress of Andrology, Malmö, Sweden September, 2002
250. The role and function of ER-beta in the development of prostate cancer Molecular mechanisms as targets in prostatic diseases, Liverpool, UK September, 2002
251. Glucocorticoid receptors and cell signalling (overview talk)”. European Respiratory Society, Annual Congress 2002, Stockholm, Sweden September, 2002
252. Estrogen receptors ENEA 2002 Münich, 10th Meeting of the European Neuroendocrine Association, Münich, Germany September, 2002
253. State-of-the-Art-Lecture: “The role of estrogen-receptor beta in control of prostate growth 26th Congress of the Société Internationale d’Urologie, Stockholm, Sweden September, 2002
254. Sterol homeostasis controlled by nuclear receptors Nuclear receptors and disease, Göteborg, Sweden September, 2002
255. Estrogen receptors: alpha and beta International Summer School on Neurotrophin and Nuclear Receptors: From Molecules to Behaviour, Lake Erken, Norrtälje, Sweden August, 2002
256. ERbeta as a regulator of cellular proliferation Nuclear Receptors 2002 - A Joint International Symposium arranged by the Center for Biotechnology (CBT), Karolinska Institutet in collaboration with the Summer University of Southern Stockholm, Huddinge, Sweden August, 2002
257. Crosstalk between PPAR and LXR: Two major regulators of lipid metabolism 14th International Symposium on Microsomes and Drug Oxidations (MDO 2002), Sapporo, Japan July, 2002
258. ERa , ERb and more” and “ED interactions with ERa and ERb Summer School/Bregenz 2002, “From genes via endocrine models to patients”, Bregenz, Austria July, 2002
259. Novel aspects on estrogen signaling and hormone dependent cancer National Cancer Centre, Tokyo, Japan July, 2002
260. Estrogen receptor b - an important and multifacetted player in estrogen signaling Conférence du Centre de recherche, Quebec, Canada July, 2002
261. Estrogen receptors XIVth World Congress of Pharmacology, Plenary lecture, San Fransisco, USA July, 2002
262. Estrogen receptor – a multifacetted player 10th World Congress on the Menopause, Plenary lecture, Berlin, Germany June, 2002
263. Estrogen signaling – a matter of thesis and antithesis Fourth Annual Symposium on Developmental & Molecular Toxicology, Development and Genetic Aspects of Breast Cancer, Madison, Wisconsin, USA June, 2002
264. New paradigms in estrogen signaling – ERb as the Deus ex machina Hormones and Genome: Basic research towards improvement of diagnostic and therapeutic medicine, Blaubeuren/Ulm, Germany May, 2002
265. On the role of ERbeta in the CNS Keystone meeting on Nuclear Receptor Superfamily, Snowbird, Utah, USA April, 2002
266. Update on the biology of ERb 6th Annual Frontiers in Estrogen Action, Amelia Island, Florida April, 2002
267. Steroid receptors 7th Congress of the European Society of Contraception, Genova, Italy April, 2002
268. Recent advances in our understanding of estrogen signalling pathways Lecture at Chinese Academy of Medical Sciences, Beijing, China April, 2002
269. Steroid receptors and transcription mechanisms: action of endocrine disruptors Swiss National Research Programme (NRP) 50 “Endocrine Disruptors”, Zürich, Switzerland April, 2002
270. Estrogen receptor – A multifaceted player 2nd Annual Lectureship inWomen’s Health Research “From estrogen receptors to management of menopause”, Washington, USA March, 2002
271. An update on the biology of estrogen receptor beta First International Nuclear Receptor Meeting in Japan, Kyoto, Japan March, 2002
272. Genomic and non-genomic actions of steroids The 5th International Congress of Neuroendocrinology, Bristol, U.K January, 2002
273. The nuclear-receptor interacting proteins 2001 Workshop on Genomic vs non-genomic steroid action: Encountered or unified views, Madrid, Spain December, 2001
274. The latest on ER beta in gynaecological and breast cancers 3rd Biennial International Meeting of the Flemish Gynaecological Oncology Group, Endocrine treatment and prevention of breast and gynaecological cancers, Brussels, Belgium November, 2001
275. Recent advances in understanding nuclear receptors Science in Japan Forum, Stockholm October, 2001
276. Nuclear receptor – environment interactions 8th ICEM, Shizuoka, Japan October, 2001
277. Nuclear receptors as target for drug development – A scientifically and commercially hot area that may serve as a role model for a new paradigm in academic research Medicon Valley BioConference 2001, Copenhagen, Denmark September, 2001
278. Molecular mechanisms of CYP induction Benzon Symposium No 48: Drug Metabolism Regulation and Importance, Copenhagen September, 2001
279. On the role of estrogen receptor beta in reproduction” and “LXRs XXVIth European Symposium on Hormones and Cell Regulation, Mont Ste Odile September, 2001
280. ER-beta: A receptor with many faces The Charles Brenton Huggins Memorial Symposium, Chicago, USA September, 2001
281. Update on estrogen receptors XXIII Congress of the European Society of Cardiology together with the 36th Annual General Meeting of the Association for European Paediatric Cardiology, Stockholm September, 2001
282. New paradigms in estrogen signalling” Nuclear Receptors – Recent Developments, Oslo, Norway August, 2001
283. Transgenic models in reproductive research 17th Annual meeting of the European Society of Human Reproduction and Embryology, Lausanne, Switzerland July, 2001
284. New paradigms in estrogen signalling – estrogen receptor beta” and “LXRalfa and LXRbeta – two novel and important regulators of cholesterol homeostasis IMCB, Singapore July, 2001
285. A tale of two estrogen receptors 7th International Summer School Behavioral Neurogenetics, Lake Erken, Norrtälje, Sweden July, 2001
286. Phenotypes of ERb knockout mice 15th Annual Symposium on The Long-Term Effects of Estrogen Deprivation, Bermuda July, 2001
287. Regulation of transcription by different estrogen receptors Bone and Tooth Society, Annual Meeting, Warwick, UK July, 2001
288. Estrogen Receptors Eukaryotic Transcription: From mechanism to function, Turku, Finland June, 2001
289. New Frontiers in estrogen signalling A Eurosterone Thematic Conference: Steroid signalling: New Frontiers, Edinburgh, Scotland June, 2001
290. ERb-ERa interplay in estrogen action FASEB Summer Research Conference Program “Steroids and Bone”, Whitefish, Montana, USA June, 2001
291. Estrogen receptor b Neuroendocrine Workshop on Hormones, Mood and Behavior, Breckenridge, Colorado, USA June, 2001
292. Estrogen signaling – New Paradigms 4th International Symposium on Women’s Health and Menopause, Washington DC, USA May, 2001
293. Novel aspects on estrogen signaling EMBO Workshop on Nuclear Receptor Structure and Function, Erice, Italy May, 2001
294. ERb biology: New Frontiers 5th Annual Frontiers in Estrogen Action, County Clare, Ireland April, 2001
295. Oestrogen receptor beta knock out leads to hyperplasia in the ventral prostate Disorders of the Prostate. Advances in Basic Mechanisms and the Implications for Clinical Management, Castres, France March, 2001
296. Estrogen receptors and Breast Cancer II International Symposium of the Portuguese Menopause Society, Menopause: Hormones and Cancer, Lisbon, Portugal March, 2001
297. Estrogen Receptor Beta – a Breakthrough in Understanding Estrogen Signaling Mayo Clinic, Rochester, USA February, 2001
298. The mechanism of action of estrogens – The role of ERb 1st Meeting of the Network “Environmental Estrogens and their Effects in Health and Disease”, Athens, Greece January, 2001
299. Molecular aspects of estrogen receptors alpha and beta Experimental Biology 2001, The American Association of Immunologists, Orlando, Florida, USA January, 2001
300. The nuclear receptor super gene family – developments and highlights XIth International Congress on Genes, Gene Families and Isozymes; Stockholm, Sweden January, 2001
301. ERa and ERb : “The Yin-Yang principle of estrogen action 23rd Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA December, 2000
302. Mechanisms of estrogen action: the role of ERbeta Keynote Lecture at Garvan Symposium “Estrogens & Womens Health”, Sydney, Australia November, 2000
303. Estrogen receptor b - a paradigm shift in understanding estrogen action European Medal Lecture. 191st Meeting of the Society for Endocrinology, London, U.K November, 2000
304. Estrogen receptors and control of proliferation Keynote Lecture at Steroid receptor and cell signaling, Cincinnati, University of Cincinnati, USA November, 2000
305. Estrogen receptor b – a paradigm shift in understanding estrogen action Keynote Lecture at Hormones and cancer 2000 and Aromatase 2000 and the 3rd generation, Port Douglas, Queensland, Australia November, 2000
306. Estrogen receptor b - a paradigm shift in our view on estrogen signaling and endocrine disruption E.hormone 2000 – the cutting edge of endocrine disrupter research, Tulane University, New Orleans, U.S.A October, 2000
307. Estrogen receptors Cardiovascular Disease and Hormone Replacement Therapy, IMS Workshop Royal Society of Medicine, London, U.K October, 2000
308. Estrogen receptors Cinquièmes Journées Européennes de la Sociéte Francaise de Gynécologie, Paris, France October, 2000
309. Rational drug design based on steroid hormones and their receptors and the interaction between academic research and KaroBio AB BioTech Forum, Älvsjömässan, Stockholm, Sweden October, 2000
310. Nuclear Receptors in Health and Disease”, Huddinge, Sweden: “Estrogen receptor b - A paradigm shift in understanding estrogen action A Joint International Symposium arranged by the Center for Biotechnology (CBT), Karolinska Institutet and EUROSTERONE in collaboration with the Summer University of Southern Stockholm September, 2000
311. Estrogen receptor-b: A paradigm shift in understanding estrogen action Pannon Symposium, Tissue-selective estrogen action: from basic science to the clinical practice, Pécs, Hungary September, 2000
312. The role of the ERb in oestrogen mediated carcinogenesis EUROTOX 2000, XXXVIII European Congress of Toxicology, London September, 2000
313. Novel mechanisms in estrogen signalling” and “Nuclear receptor regulated lipid homeostasis FEBS Advanced Study Institute, International Summer School on New dimensions in the regulation of gene expression, Spetses, Greece August, 2000
314. Potential of genomics for diagnosis and drug development – the example of the steroid receptor superfamily Third Annual Symposium on “Functional genomics – the human touch”, Gothenburg, Sweden August, 2000
315. Recent developments in our understanding of estrogen action: Estrogen Receptor b VIth International Conference on Hormones, Brain and Behavior & The Society for Behavioral Neuroendocrinology, Madrid, Spain August, 2000
316. On a paradigm shift in our understanding of estrogen mechanism of action: Discovery of estrogen receptor b 14th Ecdysone Workshop, Rapperswil, Switzerland July, 2000
317. Physiological Role of Estrogen and Estrogen Receptors International Meeting on Women’s Health and Menopause, NIH, Washington D.C., USA July, 2000
318. Nuclear receptors in control of lipid homeostasis 6th Reisenburg International Symposium, Thyroid 2000: From bench to bedside, from gene to patient, Reisenburg, Germany June, 2000
319. Role of estrogen receptor a and b in steroid hormone-dependent tissues and cancers Hormone-dependent Cancers and Nuclear Receptors, Saitama, Japan June, 2000
320. Nutrients in control of gene regulation 7th Nordic Nutrition Congress, Mariehamn, Ã…land June, 2000
321. Estrogen receptor b - A paradigm shift in understanding estrogen action ASPET, Burroughs Wellcome Fund Lecture, Boston, USA June, 2000
322. New dimensions in estrogen receptors’ mechanisms of action Annual Meeting of the German Endocrine Society, München, Germany June, 2000
323. Estrogen receptor b - a paradigm shift in understanding estrogen action Estrogens: bone and vascular targets, Paris, France May, 2000
324. Estrogen receptor b - role in reproduction Int. Conf. on the Female Reproductive Tract, Frauenwörth, Germany May, 2000
325. ERb - a new dimension in estrogen action Swiss Bone and Mineral Society, Basel, Switzerland May, 2000
326. A paradigm shift in our understanding of estrogen action SFT seminar on Phytoestrogens, Stockholm, Sweden May, 2000
327. Biological role of ERa and Erb 27th European Symposium on Calcified Tissues, Tampere, Finland May, 2000
328. News and views on nuclear receptors Nuclear Receptors in the Brain, Potential targets for therapeutic agents, Oegstgeest, The Netherlands April, 2000
329. Coorganizer and cochairman 4th Annual Frontiers in Estrogen Action, Palm Beach, Florida, USA April, 2000
330. Roles of estrogen receptor b in the CNS Sixth International Stockholm/Springfield Symposium on Advances in Alzheimer Therapy, Stockholm, Sweden April, 2000
331. Estrogen receptors; modulation and clinical practise Congres Infertiliteit, gynaecologie en obstetrie anno 2000, Rotterdam, Netherlands March, 2000
332. ERb - Surprises never end Keystone Symposia, Nuclear Receptors 2000, Steamboat Springs, Colorado, USA March, 2000
333. ERb - a paradigm shift in our understanding estrogen action Estrogens: From research to clinical practice (Hormone-dependent cancers and menopause), Montpellier, France March, 2000
334. Estrogen receptors a and b in the rodent mammary gland The Second International Symposium on: The Molecular Biology of Breast Cancer, Lillehammer, Norway March, 2000
335. The estrogen b-receptor and its interaction with phytoestrogens” Symposium on Phytoestrogen Research Methods, Chemistry, Analysis, and Biological Properties, Tucson, Arizona, USA January, 2000
336. New insights in ER research – The ER b 2nd Biennial International Meeting Flemish Gyneacological Oncology Group, Brussels, Belgium December, 1999
337. Recent advances in our understanding of receptor mediated induction of drug-metabolizing enzymes International Symposium on Induction of Drug Metabolism From Molecular Mechanisms to Drug Approval, Stockholm, Sweden December, 1999
338. ERb: More Surprises SERMs: Implications for Prevention and Treatment of Breast Cancer, Philadelphia, USA November, 1999
339. Physiological role of estrogen and estrogen receptors National Institutes of Health, Menopause and Women’s Health – a Global Approach, USA November, 1999
340. Novel nuclear receptors – a paradigm shift in drug development Svenska Mässan, “From Idea to Blockbuster”, Gothenburg November, 1999
341. ERb - new dimensions in estrogen mechanism of action The 9th International Menopause Society World Congress on the Menopause, Yokohama, Japan October, 1999
342. ERb - a new dimension in understanding of estrogen action Japanese Endocrine Disruptor Research Project, Tokyo, Japan September, 1999
343. The role or estrogen receptor beta in male reproductive tissues International workshop: Estrogens and Male Reproduction (EMR), Isola Capo Rizzuto, Crotone, Italy September, 1999
344. Estrogen receptor beta – new developments ECCO10 – the European Cancer Conference, Vienna, Austria September, 1999
345. New horizons in estrogen mechanisms of action – estrogen receptor b Neuronal and cognitive effects of oestrogens, London, England September, 1999
346. Recent advances in our understanding of the respective biological roles of estrogen receptor a and estrogen receptor b 6th International Congress on Hormones and Cancer, Jerusalem, Israel September, 1999
347. Nuclear receptors – and update 11th International Conference on Cytochrome P450, Sendai, Japan August, 1999
348. Estrogen receptor b: structure and function Gordon Conference Research on Hormonal Carcinogenesis, New Hampshire, USA August, 1999
349. Steroid hormones, nutrients, nuclear receptors and coactivators – important players in control of gene expression XIIIth International Symposium on Gnotobiology, Djurönäset, Stockholm June, 1999
350. ”ERb: New excitement Gordon Conference on Mammary Gland Biology, Hennecker, New Hampshire, USA June, 1999
351. Biology and mechanism of action of estrogen receptor b EMBO Workshop, Steroid and Nuclear receptors, Villefranche, France May, 1999
352. Estrogen receptors - current concepts Endothelial derived vasoactive substances and free radicals in perinatal biology, NIH, Washington May, 1999
353. New dimensions in nuclear receptor signaling Directors Seminar, NIH, Washington May, 1999
354. The nuclear receptors Frontiers in Estrogen Action, Dana Point, California, USA April, 1999
355. Recent advances in our understanding of nuclear receptor action German Society of Endocrinology and German Society of Human Genetics, International Symposium on Breast and Prostate Cancer: Genes, Hormones and the Environment, Casle Elmau, close to Garmisch-Partenkirschen, Germany April, 1999
356. Nuclear receptors involved in lipid metabolism: PPARa, ERb, OR-1 and RLD-1 18th Joint Meeting of the British Endocrine Societies, Insulin resistance and cardiovascular disease: mechanisms and consequences, Bournemouth, UK April, 1999
357. New dimensions in estrogen mechanism of action offer new hopes for therapy of diseases in the postmenopausal woman The 4th Congress of the European Society for Gynecologic and Obstetric Investigation, Madonna di Campiglio, Italy March, 1999
358. Estrogen Receptors: Alpha and Beta Estrogen and progesterone receptors and their ligands, Society for Gynecologic Investigation, Atlanta, USA March, 1999
359. Estrogen receptors and other nuclear receptors Women’s Health Roundtable, Pasadena, USA February, 1999
360. Properties, distribution & function of ERb” Endocrine Disruptors, Keystone, Lake Tahoe, USA February, 1999
361. ERb - an antioxidant receptor Int. Conference on Diet and Prevention of Cancer, Tampere, Finland January, 1999
362. ERb - a new paradigm in estrogen mechanism of action Nobelsymposium 113, “Estrogens and women’s health – benefit or threat?”, Karlskoga, Sweden January, 1999
363. Downstream Modulators of PPAR Action Keystone Symposium on The PPARs: Transcriptional links to obesity, diabetes and cardiovascular disease, Keystone Resort, Colorado January, 1999
364. Nuclear Receptors ILSI Health and Environmental Science Institute, Nassau, Bahamas January, 1999
365. The estrogen receptor b and its interaction with phytoestrogens 23rd International LOF-symposium on phyto-oestrogens, Gent, Belgium January, 1999
366. Estrogen receptor b - new exciting developments AACR Special Conference on The Steroid Receptor Superfamily, Indian Wells, CA, USA January, 1999
367. ”Estrogen receptor b: Functional role for a new estrogen receptor in mammalian development The first Märta Philipson Symposium in Pediatric Research, Stockholm December, 1998
368. Keynote Lecture “Estrogen receptor b - a new dimension in estrogen mechanism of action Sixth Annual Meeting of Japan Hormonal Steroid Society, Osaka, Japan November, 1998
369. Introduction into the nuclear receptor field Nuclear Receptors - Minisymposium, Oslo, Norway November, 1998
370. Estrogen receptors a and b Estrogens and Human Health, Urbana, Illinois, USA October, 1998
371. Estrogen receptor b Breast and menopause, Wroclaw, Poland October, 1998
372. Intracellular transacting signals Sex-Steroids and the Somatotropic Axis, La Playa, Naples, Florida, USA October, 1998
373. Recent paradigm shifts in our understanding of estrogen signalling Steroid hormone action at the turn of the century. Four decades after puff induction by ecdysone, Marburg, Germany October, 1998
374. New dimensions in estrogen action: ERb”. Sex-Hormones, Their Receptors and Biological Response, Louisville, Kentucky, USA October, 1998
375. Estrogen receptor b - an important player in estrogen action 3rd Int. Symp on Hormonal Carcinogenesis, Seattle, Washington, USA September, 1998
376. Basic concepts of hormone-receptor interactions European Teratology Society, Stockholm September, 1998
377. Coactivators and corepressors in nuclear receptor function” and ”Novel insights into the role of orphan nuclear receptors NATO/FEBS Advanced Study Institute, International Summer School on Molecular Mechanisms of Transcellular Signalling: From Membrane Receptors to Trancription Factors, Spetsai, Greece August, 1998
378. Physiology and molecular biology of estrogen receptor b The Society for the Study of Reproduction, Texas, USA August, 1998
379. Peroxisome proliferator activated receptor or PPAR Int. Congress of Pharmacology, München, Germany July, 1998
380. Expression and function of the new estrogen receptor: ERb Gordon Research Conference, New Hampshire, USA July, 1998
381. PPAR activation and its consequences in experimental animals Int. Congress of Toxicology, Paris, France July, 1998
382. ”Estrogen receptor b - a new dimension in estrogen mechanism of action Xth Int. Congress on Hormonal Steroids, Québec, Canada June, 1998
383. Novel mechanisms of estrogen action” and ”Estrogen receptor b - a new hope for tissue specific HRT 3rd International Symposium on Women’s Health and Menopause, Risk Reduction Strategies - Improved Quality of Health, Florence, Italy June, 1998
384. Estrogen Receptor b Laboratory Medicine 98, Turku, Finland June, 1998
385. The steroid/thyroid hormone receptor family European Federation of Endocrine Societies, 2nd Postgraduate Course in Molecular and Cellular Endocrinology, Turku, Finland June, 1998
386. In vitro studies for understanding toxic mechanisms in vivo Nordtox/NordEMS-98, The 5th Nordic Toxicology Meeting, Helsinki, Finland May, 1998
387. Estrogen receptor b: A new dimension in estrogen receptor research NFOG ’98, The Federation of Scandinavian Societies of Obstetrics and Gynecology, Århus, Denmark May, 1998
388. Signalling via estrogen receptor b”. Frontiers in Estrogen Action, Rio Grande, Puerto Rico May, 1998
389. OR-1 and peroxisome proliferator-activated receptors (PPAR) - two major regulators of lipid metabolism 18th Blankenese Conference, Orphan receptors and novel ligands, Hamburg-Blankenese, Germany May, 1998
390. Steroid receptors - New dimensions IV European Congress of Endocrinology, Sevilla, Spain May, 1998
391. Biology of the novel estrogen receptor ERb 2nd Congress of Molecular Medicine, Berlin, Germany May, 1998
392. Structure and properties of estrogen receptor b”. Estrogens as initiators and promoters in breast and prostate cancer, Chantilly, Virginia, USA March, 1998
393. “Estrogen b receptor in prostate International Symposium on Biology of Prostate Growth, Bethesda, Maryland, USA March, 1998
394. New developments in nuclear receptors: crosstalk, coactivators and orphan receptors Tokyo Medical Association Meeting (Tokyo Society of Medical Science), Tokyo, Japan February, 1998
395. New developments in nuclear receptors: crosstalk, coactivators and orphan receptors Symposium for Sex Difference and Similarity Society, Tokyo, Japan February, 1998
396. Mechanism of Action of Estrogen Receptor b Keystone Symposia on Breast and Prostate Cancer, Copper Mountain, Colorado, USA February, 1998
397. Novel developments in nuclear receptors: postreceptor signalling and estrogen receptor b University of Colorado Health Sciences Center, Department of Pathology, Denver, USA February, 1998
398. Cochair at the symposium ”Manipulation of Science by Vested Interests: Money and Power versus Public Health AAAS Annual Meeting and Science Innovation Exposition, Philadephila, Pennsylvania February, 1998
399. Estrogen receptor b predicted effects of estrogen Keystone Symposia on Molecular & Cellular Biology, Nuclear Receptor Gene Family Conference, Lake Tahoe, Nevada January, 1998
400. The Estrogen Receptor Beta Distinguished lecturer seminar, NIEHS, Research Triangle Park, North Carolina, USA December, 1997
401. Nuclear receptors as mediators of chemical-induced toxic responses: Mechanism of peroxisome proliferator-activated receptor Seminar at CIIT, North Carolina, USA December, 1997
402. Estrogen receptor isoforms Receptor Biology Roundtable, Center for Executive Education at Babson College, Massachusetts, USA December, 1997
403. Orphan receptors - a rapidly developing field with nutritional implications Academy of Military Medical Sciences, Beijing, China November, 1997
404. PPAR and OR-1: Two major regulators of lipid metabolism EMRC Workshop ”Crosstalk between steroid receptors and other transcription factors: molecular basis for immunomodulatory and anti-inflammatory effects of steroids”, Ottrott, Alsace, France November, 1997
405. ”Estrogen receptor b”. Molecular basis of sex hormone receptor function - New targets for intervention, Berlin, Germany October, 1997
406. OR1 and PPAR - two major regulators of lipid metabolism 9th International CBT Symposium, Steroid and Orphan Nuclear Receptors, Stockholm, Sweden October, 1997
407. ”Cloning, expression and role of a novel estrogen receptor XVCongrès de la Société Francaise d’Endocrinologie, Paris, France October, 1997
408. Expression and Function of ERb Workshop on Estrogen Action, New Jersey, USA October, 1997
409. Impact of environmental pollutants on nuclear receptors The fifth CFN Symposium, Effects of Toxicants on Gene Expression and Intracellular Signalling, Saltsjöbaden, Sweden September, 1997
410. Ligand activated transcription factors in control of cytochrome P450 17th International Congress of Biochemistry and Molecular Biology, San Francisco, USA August, 1997
411. “Estrogen receptor b - tissue distribution and functional properties XXXIII International Congress of Physiological Sciences IUPS 1997, St. Petersburg, Russia July, 1997
412. Hormone action of a new estrogen receptor: ER-b“. NIEHS Conference on Estrogens in the Environment IV: Linking Fundamental Knowledge, Risk Assessment, and Public Policy, Arlington, Virgina, USA July, 1997
413. Fatty acids and gene expression Marabou symposium: Diet and genetic interactions, Stockholm, Sweden June, 1997
414. Receptor mediated toxic responses Eurotox Congress in collaboration with the Danish Society of Pharmacology and Toxicology, Aarhus, Denmark June, 1997
415. Cloning and function of the novel estrogen receptor b Paediatric Endocrinology 1997, Joint Meeting of ESPE and LWPES, in collabora-tion with APEG, JSPE and SLEP, Stockholm, Sweden June, 1997
416. ERb: a new isoform of the estrogen receptor The Endocrine Society 79th Annual Meeting, ENDO ‘97, Minneapolis, USA June, 1997
417. Free fatty acids - mediators of GH action The paradoxes of growth hormone action, Fiskebäckskil, Sweden May, 1997
418. Identification and characterization of ERb Frontiers in Estrogen Action, Key West, USA May, 1997
419. Recent insights into mechanisms of glucocorticoid action - new crosstalk and coactivators” NIH, Bethesda, USA April, 1997
420. “a and b estradiol receptors Mechanisms of action of estrogens and physiological needs, Chantilly, France April, 1997
421. “Functional characteristics of estrogen receptor b 31st International Meeting of the European Society for Clinical Investigation (ESCI), Kiel, Germany March, 1997
422. .: ”What new can we learn about estrogens in light of the discovery of the novel estrogen receptor b University of Leicester, MRC Toxicology Unit, Leicester, U.K February, 1997
423. ”Government - Industry - University interaction” Workshop on ”Universities in the Cross-Streams of Globalisation and Information Technology”, Italy February, 1997
424. Characterization of a novel estrogen receptor Gordon Research Conference on Hormone Action, New Hampshire, USA January, 1997
425. Novel insights into the mechanism of action of estrogens in the light of the discovery of a second estrogen receptor gene Gordon Research Conference on Hormonal Carcinogenesis, Tilton, USA January, 1997
426. Novel insights into estrogen mechanism of action FEBS Special Meeting, Cell Signalling Mechanisms; from membrane to nucleus, Amsterdam, The Netherlands January, 1997
427. Novel aspects of environmentally and dietary related ligand activated transcription factors Deutsche Forschungsgemeinschaft, Symposium Hormonally Active Agents in Food, Kaiserslautern, Germany October, 1996
428. ”Cloning, Expression and Function of a Novel Estrogen Receptor Estrogen and the Blood Vessel Wall Symposium, Seattle, Washington, USA September, 1996
429. Characteristics and function of the novel estrogen receptor b Steroid Receptor Superfamily Symposium, Madison, USA September, 1996
430. Fatty acids and gene regulation Tore Nilson symposium on ”Aspects of hormonal regulation of artherosclerosis”, Stockholm September, 1996
431. “Regulation of PPAR by glucocorticoids and nor-epinephrine SPBBM, Colloque GERMÉ, PPARs, nutriments and xenobiotics: as mediators of cell regulation? Dijon, France September, 1996
432. Steroid receptors as molecular targets for drug development”. KBF-Symposium Molecuar Targets for Drug Development, Braunschweig, Germany September, 1996
433. Orphan nuclear receptors - an exciting development of the steroid/thyroid hormone receptor field” and ”Growth hormone as determinant of hepatic sexual dimorphism” NATO/FEBS Advanced Study Institute, International Summer School on Molecular Mechanisms of Signaling and Targeting, Spetsai, Greece August, 1996
434. Negative cross-talk between the glucocorticoid receptor and other signal transduction pathways International Society for Endocrinology, San Francisco, USA June, 1996
435. Orphan receptors and the search for endogenous ligands 2nd Oulu Symposium on Molecular Approaches to Reproductive Health, Oulu, Finland May, 1996
436. Cloning of a novel estrogen receptor (ERb) Keystone Symposia on Molecular and Cellular Biology, Steroid/Thyroid/Retinoic Acid Gene Family, Lake Tahoe, California March, 1996
437. Future scenarios for Biocenters From Invention to Business in Biotechnology, Helsinki, Finland January, 1996
438. Control of gene expression by fatty acids: Role of the peroxisome proliferator activated receptor (PPAR) The British Biochemical Society Meeting No. 657, Aberdeen, U.K December, 1995
439. Activation of peroxisome proliferator activated receptor (PPAR) International Symposium on ”DHEA Transformation into Androgens and Estrogens in Target Tissues: Intracrinology”, Québec, Canada September, 1995
440. Ligand activated transcription factors International Symposium on Control Mechanisms of Carcinogenesis, Mainz, Germany September, 1995
441. Glucocorticoid receptor and transcription factor interactions The European Respiratory Society Annual Congress, Barcelona, Spain September, 1995
442. Mechanism of signal transduction of PPAR 7th International CBT Symposium: Nuclear Orphan Receptors: Novel Regulators in Physiology and Pathology, NOVUM, Sweden September, 1995
443. Functional organization of the dioxin receptor-Arnt complex Gordon Research Conference on Hormone Action, New Hampshire, USA July, 1995
444. Regulation of gene expression by fatty acids” The Rank Prize Funds, Mini-Symposium on Nutrients as Regulators (Nutrient Sensing), Grasmere, England July, 1995
445. Receptor-mediated toxicity” VII International Congress of Toxicology, Seattle, USA: July, 1995
446. Mechanisms of Regulation of Drug Metabolizing Enzymes Pharmacology & Toxicology 50th Anniversary Symposium, Perspectives in the development and safety of new medicines: Biological diversity and structure specificity, Copenhagen, Denmark May, 1995
447. ”Functional Analysis of the glucocorticoid receptor”. 12th International Symposium of the Journal of Steroid Biochemistry and Molecular Biology. ”Recent Advances in Steroid Biochemistry and Molecular Biology”, Berlin, Germany May, 1995
448. Transcriptional activation by the glucocorticoid receptor: Role of the t1 domain EMBO Workshop; Structure and Function of Steroid and Nuclear Receptors, Alghero, Sardinia, Italy: April, 1995
449. Mechanism of action of the glucocorticoid receptor and of the peroxisome proliferatoractivated receptor (PPAR) Sterling lecture, University of Pennsylvania, Philadelphia, USA: March, 1995
450. ”Fatty acid signalling of peroxisome proliferator-activated receptor The Aspen Institute: Peroxisomes: Biology and Role in Toxicology and Disease, Aspen, USA January, 1995
451. Mechanisms of activation and action of PPAR (Peroxisome Proliferator Activated Receptor An AACR Special Conference in Cancer Research: ”Mechanism of action of retinoids, vitamin D, and steroid hormones”, Whistler, British Columbia, Canada January, 1995
452. Functional architecture of the dioxin receptor/arnt heterodimer Keystone Symposia conference on ”Molecular Toxicology”, Keystone, USA January, 1995
453. Functional organization of the glucocorticoid receptor Worcester Foundation for Experimental Biology, Gregory Pincus Lecture, Shrewsbury, MA, USA November, 1994
454. Nuclear Receptors and Chemical Carcinogenesis". Receptor Mediated Mechanisms in Carcinogenesis, Lyon, France November, 1994
455. Mechanisms of growth hormone regulation of sexually differentiated gene expression in the liver Symposium on "Bridging Basic Science and Liver Disease". Boston, USA: November, 1994
456. "University-Industry Partnership in Sweden Health Research in Quebec and the world: today and tomorrow: Montréal, Canada October, 1994
457. "Activation of the PPAR IX International Congress on Hormonal Steroids. Dallas, Texas, USA September, 1994
458. Functional analysis of the glucocorticoid receptor University of Wisconsin-Madison: "Steroid Receptor Superfamily Symposium", Madison, USA September, 1994
459. Recent developments in the field of the nuclear receptor supergene family" and "The dioxin receptor - another ligand activated transcription factor NATO Advanced Study Institute on Molecular Mechansims of Transcellular Signaling: "From the Membrane to the Gene", Spetsai, Greece August, 1994
460. Fatty acid activation of PPAR XIIth International Congress of Pharmacology, Montréal, Québec, Canada July, 1994
461. Novel Aspects on Ligand Activated Transcription Factors in Control of Cytochrome P-450 Second International Symposium on Hormonal Carcinogenesis, Novum, Stockholm July, 1994
462. "Functional analysis of flanking sequences of sex-specific P-450 genes expressed in rat liver 10th International Symposium on Microsomes & Drug Oxidations, Toronto, Canada July, 1994
463. Fatty acid control of gene expression via a member of the nuclear receptor supergene family (PPAR) United European Gastroenterology week, Oslo, Norway June, 1994
464. Nuclear receptors - an expanding super gene family The Lundberg Symposium, Gothenburg May, 1994
465. The functional architecture of the glucocorticoid receptor" The First International Conference on Steroids and Bone, Florence, Italy May, 1994
466. Activation of the PPAR Nordic Meeting on Biochemical and Medical Aspects of Lipid Metabolism in Peroxisomes and Mitochondria, Huddinge, Sweden: May, 1994
467. Functional architecture of the glucocorticoid receptor and characteristics of some novel members of the steroid/thyroid hormone receptor super family Symposium on Eukaryotic Gene Expression and Regulating Signals, New York: April, 1994
468. The dioxin receptor - another ligand activated transcription factor Keystone Symposia on Molecular and Cellular Biology, Taos, New Mexico February, 1994
469. Novel aspects on ligand activated transcription factors Norsk Biokjemisk Selskaps 30 årsjubileumsmöte January, 1994
470. Receptor-mediated regulation of drug metabolising enzymes" Biochemical Society Meeting 649, London, U.K December, 1993
471. Thyroid and steroid hormone receptor family 4th International Thyroid Symposium on "Genetic defects of thyroid and steroid hormons receptors: molecular basis and clinical expression", Ulm, Germany: November, 1993
472. Mechanisms of sex differentiation and growth hormone regulation of hepatic P450 genes in the rat". Instituto Juan March de Estudios e investigaciones, Centre for International Meetings on Biology. Workshop on Neuroendocrinology of Growth. Madrid, Spain October, 1993
473. "Mechansims of sex differentiation and growth hormone regulation of hepatic P450 genes in the rat 8th International Conference on Cytochrome P450, Lisbon, Portugal: October, 1993
474. "Activation of PPAR by fatty acids 5th International CBT Symposium, "Intracellular hormone receptors and ligand-dependent transcriptional regulation", Stockholm, Sweden September, 1993
475. Mechanisms of Induction of Cytochrome P450 by Environmental Agentsparticipation of Ligand Activated Transcription Factors from Two Different Gene Families Second Asia-Pacific Symposium on Environmental and Occupational Health – Toxico-logical Studies, Kobe, Japan July, 1993
476. "The functional architecture of the glucocorticoid receptor 22nd Meeting of the Federation of European Biochemical Societies, Stockholm, Sweden: July, 1993
477. Steroid/thyroid hormone receptors" The Karolinska Institute and the Summer University of Southern Stockholm, "Understanding Signal Transduction", Stockholm, Sweden June, 1993
478. Basic aspects on steroid hormone actions" 18th International Congress of Chemotherapy, "Principles of endocrine treatment of cancer - basic aspects and clinical regimens", Stockholm, Sweden June, 1993
479. Fatty acid activation of PPAR Biochemistry, Endocrinology and Pharmacology of Nuclear Receptors, Marburg, Germany May, 1993
480. "Fatty acid activation of the peroxisome proliferator activated receptor (PPAR), a member of the nuclear receptor supergene family Symposium on Fat and Gene Expression, New Orleans, U.S.A March, 1993
481. Control of Gene Expression by Fatty Acids and Retinoids International Symposium on Antioxidants and Disease Prevention, Biochemical, Nutritional, and Pharmacological Aspects, Stockholm, Sweden January, 1993
482. Structure and function of the glucocorticoid receptor" 11th International Symposium of The Journal of Steroid Biochemistry and Molecular Biology "Recent advances in steroid biochemistry and molecular biology", Seefeld, Austria: January, 1993
483. Receptor Mediated Biological Processes Implication for Evaluating Carcinogens, Austin, Texas. December, 1992
484. Molecular Nutrition: Regulation of Gene Expression by Fatty Acids Perspectives in Nutrition Research Towards Year 2000, Oslo, Norway December, 1992
485. Induction of cytochrome P450 1A isozymes by heterocyclic amines and other food derived compounds The 23rd International Symposium of the Princess Takamatsu Cancer Research Fund, Tokyo, Japan November, 1992
486. Structure and function of the glucocorticoid receptor Functions and structures of genes and proteins, Mariehamn, Ã…land November, 1992
487. Hormonal regulation of Cytochromes P-450 American association for the study of liver diseases, Chicago, Illinois, USA November, 1992
488. Functional architecture of the glucocorticoid receptor Invited lecturer at Collége de France, Paris, France October, 1992
489. Functional architecture of the glucocorticoid receptor The Karolinska-Minnesota Frontiers of Medicine Symposium, Minnesota, USA October, 1992
490. Functional architecture of the glucocorticoid receptor Invited lecturer at University of California, Berkeley, USA: October, 1992
491. The molecular biology of the glucocorticoid receptor Keith Harris lecture, Australian Endocrine Society, Adelaide, Australia October, 1992
492. Why are there male and female livers and kidneys? 11th International Conference on Comparative Physiology, The Differences between the sexes, Crans-sur-Sierre, Switzerland September, 1992
493. The functional architecture of the glucocorticoid receptor" The University of Oslo, Jahreföreläsning, Oslo, Norge September, 1992
494. Determinants for DNA binding site recognition by the glucocorticoid receptor". "Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor NATO/FEBS on New Developments in Lipid-Protein Interactions and Receptor Function, Spetsai, Greece August, 1992
495. "Mechanisms of regulation of expression of hepatic cytochrome P-450". 9th International Symposium on Microsomes and Drug Oxidations, Jerusalem, Israel: July, 1992
496. "Functional analysis of the three domains of the glucocorticoid receptor" 5th International congress on Cell Biology, Madrid, Spain July, 1992
497. Overexpression in Bacteria, Yeast and Eukaryotic Cells of Steroid Receptors and Steroid Receptor Domains Endocrine Society Meeting, San Antonio, Texas, USA June, 1992
498. On the structure and function of the glucocorticoid receptor" Centre de Recherche du Chul, Québec, Canada May, 1992
499. Molecular biology of the glucocorticoid receptor NOMBA, Progress in Molecular Biology, Helsinki, Finland May, 1992
500. Mechanism of action of steroid hormones Wallenberg Symposium, The Metabolic syndrome, Gothenburg, Sweden May, 1992
501. Structural and functional studies on the glucocorticoid receptor Keystone Symposia on Molecular and Cellular Biology, Steroid/thyroid receptor gene super family, Tamarron, Colorado, USA February, 1992
502. TCDD receptor(s) and their relevance for carcinogenesis European Research Conference on "Mechanism in Toxicity", Klingenthal, Alsace, France November, 1991
503. Hepatic steroid metabolism is controlled by the sexually dimorphic pattern of growth hormone secretion in both normal and dwarf rats" International Symposium on A Molecular View of Steroid Biosynthesis and Metabolism, Jerusalem, Israel: October, 1991
504. Molecular mechanisms in regulation of cytochrome P-450 gene expression". 7th International Conference "Biochemistry & Biophysics of Cytochrome P-450; Structure & Function, Biotechnological & Ecological Aspects", Moscow, U.S.S.R August, 1991
505. Structure and Function of the Three Domains of the Glucocorticoid Receptor Arolla Workshop 1991 "From Receptor to Gene", Arolla, Switzerland: August, 1991
506. Structure and Function of the Three Domains of the Glucocorticoid Receptor" Gordon Conference on Hormone Action, New Hampshire, USA August, 1991
507. Glucocorticoid receptor: structural and functional studies" 10th International Symposium of the Journal of Steroid Biochemistry and Molecular Biology, Paris, France May, 1991
508. Regulation of rodent cytochrome P-450 gene expression by steroid hormones Cytochrome P450: Advances and prospects, Atlanta, USA April, 1991
509. Sexual dimorphism of hepatic steroid hormone metabolism and its significance for chemical hepatocarcinogenesis First International symposium on hormonal carcinogenesis, Cancun, Mexico March, 1991
510. The molecular biology of the glucocorticoid and dioxin receptors" Xenobiotics and Cancer: Implications for chemical carcinogenesis and cancer chemotherapy, Tokyo, Japan November, 1990
511. The glucocorticoid receptor: Structure, function and regulation" Symposium in honour of Professor Minor J. Coon, Ann Arbor, USA November, 1990
512. Comparative Studies of the Glucocorticoid and TCDD-Receptors Hepatic Metabolism and Disposition of Endo- and Xenobiotics, Freiburg, Germany October, 1990
513. Molecular biology and physiology of TCDD receptor - DNA interactions" Biological Basis For Risk Assessment of Dioxins & Related Compounds, Banbury, USA: October, 1990
514. "TCDD receptor: physicochemical characteristics and its significance for toxicological effects" First Düsseldorf Symposium on Immunotoxicology: Molecular Mechanisms of Dioxin Action on Cell Growth and Differentation, Düsseldorf, Germany October, 1990
515. Steroid Receptors I: General background, steroid structure and metabolism, purification and cloning of steroid receptors, members of the steroid receptor supergene family". "Steroid receptors II: Regulation of expression of the glucocorticoid receptor (GR) gene. Bacterial expression of the DNA binding domain DBDr) of GR. The three-dimensional structure of the DBDr-DNA complex NATO ASI on Biological Signal Transduction, Spetsai, Greece: August, 1990
516. Steroid receptor-DNA interactions Eighth international conference on Methods in protein sequence analysis, Kiruna, Sweden: July, 1990
517. Receptor-mediated regulation of gene expression VIIIth International Symposium Microsomes and Drug Oxidations, Karolinska Institutet, Stockholm, Sweden: June, 1990
518. On the use of molecular biology in endocrinology Scandinavian Physiological Society Meeting, Lund, Sweden May, 1990
519. Mechanism of dioxin regulation of cytochrome P-450" NORDTOX-90, 1st Nordic Conference of Toxicology and 8th Annual Meeting of Nordic Environmental Mutagen Society, Beito, Norway March, 1990
520. Ligand-steroid receptor interactions Berzelius symposium, The Swedish Society of Medicine, Stockholm, Sweden March, 1990
521. Mechanisms of steroid nonresponsiveness in mutant cell lines Steroid Receptors, Transcription Factors, and Gene Expression, San Diego, USA February, 1990
522. Hormonal Regulation of P-450 Gene Expression" and "Xenobiotic Regulation of P-450 Gene Expression NATO Advanced Study Institute on "Molecular aspects of monooxygenases and bioactivation of toxic compounds", Cesme, Izmir, Turkey September, 1989
523. Nutrition and cancer Fourth International Symposium in Hematology and Oncology, Stockholm, Sweden September, 1989
524. The cytochromes P-450 of brain and their role in the metabolism of neurosteroids Biochemical Society meeting, Host Colloquium on "Development of Mixed-Function Oxidases", Surrey, UK July, 1989
525. Mechanisms of GH effects on liver cytochrome P-450 isozymes FASEB Summer Research Conference: "Nutrients, Gene Expression, and Cancer", Copper Mountain, Colorado, USA July, 1989
526. Expression, structure and regulation of the glucocorticoid receptor Molecular Biology and Pathophysiology of Hormone Regulation and Actions, Heidelberg, West Germany July, 1989
527. Expression and structure of the Glucocorticoid Receptor" 9th International symposium of the Journal of Steroid Biochemistry, Las Palmas, Canary Islands, Spain May, 1989
528. Role of ligand binding in glucocorticoid receptor function Molecular biology in drug design and in drug production, Uppsala, Sweden December, 1988
529. Glucocorticoid recepto NATO Advanced Research Workshop on "Molecular Mechanisms and Consequences of Activation of Hormone and Growth Factor Receptors, Nafplion, Greece September, 1988
530. Structure, function and regulation of the glucocorticoid receptor Fourth International Symposium on Cellular Endocrinology, Lake Placid, USA August, 1988
531. Glucocorticoid & dioxin receptors - a comparison 6th Biophysics-Biochemistry of cytochrome P-450 congress, Vienna, Austria July, 1988
532. The dioxin and glucocorticoid receptors: two similar gene regulatory proteins 8th International congress of Endocrinology, Kyoto, Japan July, 1988
533. Glucocorticoids - from cloning to clinic Edinburgh, England May, 1988
534. On the Expression and Regulation of the Glucocorticoid Receptor 8th European Winter Conference on Brain Research, Tignes/Val d'Isere, France January, 1988
535. Cloning and regulation of cytochrome P45015ß and P45016a in rat liver 2nd International Workshop on P450 Gene Regulation, Airlie, Virgina, USA January, 1987
536. Mechanism of Action of Glucocorticoid Hormones 625th meeting of the Biochemistry Society on "Molecular Biology of Hormone Action" Dublin, Irland: January, 1987
537. Role of endocrine factors in the regulation of cytochrome P-450 expression 7th International Symposium on Microsomes and Drug Oxidations, Adelaide, Australia January, 1987
538. Structure, function and localization of the glucocorticoid receptor UCLA Symposia on Molecular and Cellular Biology: Steroid Hormone Action, Park City, Utah, USA January, 1987
539. Glucocorticoid mechanism of action: monoclonal antibodies as experimental tools Second Int. Symposium in Hematology and Oncology organized by The Hematology Collaborating Group at the Karolinska Hospital under the auspices of the Karolinska Institute in honour of Prof. J.G. Waldenström: Immunoglobulins and Growth Factors in Hematology and Oncology, Stockholm January, 1986
540. Hormonal control of sex specific cytochrome P-450 isozymes in rat liver The Molecular Biology of Drug Metabolizing Enzymes, London January, 1986
541. Regulation and expression of cytochrome P-450 in liver and brain 59th Annual Meeting of the Japanese Biochemical Society, Osaka January, 1986
542. Gene expression and hormone receptors Satellite Symposium of 7th International Congress on Hormonal Steroids: Anti-Steroids, Marbella, Spain January, 1986
543. Mechanism of action of glucocorticoid hormones NATO Advanced Research Workshop on Plant Hormone Receptors, Bonn January, 1986
544. Regulation of glucocorticoid receptor First Int. Congress on Cancer and Hormones: Endocrinology and Malignancy: Basic and Clinical Issues, Rome, Italy January, 1986
545. Glucocorticoid receptor-DNA interactions GREMI Symposium: Glucocorticoides aujourd'hui, Paris, France January, 1985
546. Monoclonal antibodies to glucocorticoid receptors Int. Symposium on Monoclonal Antibodies: Basic Principles, Experimental and Clinical Applications in Endocrinology, Florence, Italy January, 1985
547. Mechanism of sex differentiation of rat liver 3rd Meadow Brook Conference on the Molecular Mechanism of Steroid Hormone Action, Rochester, USA January, 1985
548. Biochemical and biophysical characterization of the TCDD receptor - a comparison to steroid hormone receptor 5th Int. Conference on Biochemistry, Biophysics and Induction of Cytochrome P-450, Budapest, August 1985 January, 1985
549. Glucocorticoid regulated genes Gordon Conference on Hormone Action, Kimball Union, New Hampshire, USA January, 1985
550. "Mechanisms of action of glucocorticosteroids at the subcellular level SEPCR Congress on Clinical Applications of Corticosteroids, The Hague, The Netherlands January, 1985
551. Mutagens formed in the gastro-intestinal tract IV Int. Conf. on Environmental Mutagens; Satellite Meeting Genetic Toxicology of the Diet, Copenhagen January, 1985
552. Naturally occurring carcinogens protective factors 3rd ECP Symposium on Diet and Human Carcinogenesis, Aarhus, Denmark January, 1985
553. Characterization and regulation of growth hormone receptor in rat liver 6th Int. Symposium on the Biochemistry of Exercise, Copenhagen January, 1985
554. Structure and tissue localization of the glucocorticoid receptor 7th Int. Symposium of the Journal of Steroid Biochemistry on Recent Advances in Steroid Biochemistry, Seefeld, Austria January, 1985
555. Regulation, structure and function of the glucocorticoid receptor IX Nobel Conference on Thioredoxin and Glutaredoxin Systems - Structure and Function, Lidingö, Sweden January, 1985
556. Growth hormone regulation of sex-specific hepatic cytochrome P-450 isozymes Int. Meeting on P-450 Genes and their Regulation, Airlie, USA January, 1985
557. New insights into the mechanism of glucocorticoid hormone action Meeting of the International Union of Physiological Sciences, Jerusalem, Israel January, 1984
558. Purification and DNA binding of mammalian glucocorticoid receptor Argenteuil Symposium: The Role of Receptors in Biology, Brussels, Belgium January, 1984
559. Metabolism of xenobiotic compounds Int. Symposium on Diet and Prevention of Coronary Heart Disease and Cancer, Stockholm, Sweden January, 1984
560. Recent studies on the mechanism of action of glucocorticoids IX Int. Congress of Pharmacology, London, UK January, 1984
561. Characterization of prostatic cytochrome P-450 Int. Symposium on the Regulation of Androgen Action, Montreal, Canada January, 1984
562. On the use of antibodies in studies on glucocorticoid receptor structure Int. Symposium on Hormones and Cancer, Buenos Aires, Argentina January, 1983
563. On the use of poly- and monoclonal antibodies in studies on the structure and function of the glucocorticoid receptor Nobel Symposium on Steroid Hormone Receptors: Structure and Function, Karlskoga, Sweden January, 1983
564. Studies of steroid hormone receptors in brain" II Int. Congress on Hormones and Cancer, Monte Carlo, Monaco January, 1983
565. Isoelectric focusing and enzyme-linked immunosorbent assay of steroid hormone receptors First European Congress on Cell Biology, Paris, France January, 1982
566. Studies on the hypothalamo-pituitary-liver axis: a novel concept in regulation of steroid and drug metabolism Serono Symposium No 51 on The Endocrines and the Liver, Rome, Italy January, 1982
567. The mechanism of hormone action Int. Symposium on Medroxyprogesterone Acetate, Geneva, Switzerland January, 1982
568. On the possible significance of TCDD receptor based assays in attempts to estimate environmental health hazards First American-Swedish Workshop on Individual Susceptibility to Genotoxic Agents in the Human Population, Research Triangle Park, USA January, 1982
569. Regulation of sexually dimorphic hepatic steroid metabolism by the somatostatin-growth hormone axis Meeting of the Journal of Steroid Biochemistry, Paris, France January, 1982
570. Growth hormone: a regulator of the sexually differentiated steroid metabolism in rat liver Int. Symposium on Development Pharmacology, Toronto January, 1982
571. Functional analysis of the glucocorticoid receptor by limited proteolysis II Int. Meeting on Gene Regulation by Steroid Hormones, Detroit, USA September, 1981
572. Central control of sexual differentiation of hepatic steroid metabolism in the rat V Int. Symposium on Microsomes and Drug Oxidations, Tokyo, Japan July, 1981
573. Metabolism of steroid hormones in germfree and conventional rats Int. Symposium on Nutrition and the Intestinal Flora, Saltsjöbaden, Sweden June, 1981
574. Glucocorticoid-binding proteins in rat liver Int. Symposium on Corticosteroid Treatment in Allergic Airway Diseases, Copenhagen, Denmark January, 1981
575. Induction of cytochrome P-450 and metabolic activation of mutagens in the rat ventral prostate Int. Meeting on the Prostatic Cell: Structure and Function, Buffalo, USA January, 1981
576. Role of the hypothalamo-pituitary-liver axis in sex differences in susceptibility of the liver to toxic agents Int. Meeting on Endocrines and the Environment, Morristown, USA January, 1980
577. Studies on the glucocorticoid receptor Int. Meeting on Steroid Hormone Regulation of the Brain, Stockholm January, 1980
578. The effect of intestinal microflora on the enterophepatic circulation of mercapturic acid pathway metabolites Int. Workshop on Nutrition and Cancer, Cambridge, UK January, 1980
579. The hypothalamo-pituitary-liver axis: a novel regulatory system in the control of cytochrome P-450 Int. Symposium on the Biochemistry, Biophysics and Regulation of Cytochrome P-450, Stockholm, Sweden January, 1980
580. Sexual differentiating actions of steroids on the hypothalamo-pituitary-liver axis Nobel Symposium on Central Regulation of the Endocrine System, Stockholm, Sweden January, 1979
581. Characterization of a steroid-hydroxylating cytochrome P-450 of bacterial origin IV Int. Symposium on Microsomes, Drug Oxidations and Chemical Carcinogenesis, Ann Arbor, USA January, 1979
582. Estradiol receptor analysis in human breast cancer tissue by isoelectric focusing in polyacrylamide gel Fogarty Conference on Hormones and Cancer, Bethesda, USA January, 1978
583. Central control of a cytochrome P-450-dependent steroid hydroxylase in rat liver Int. Symposium on Hormones and Brain Development, Berlin, German Democratic Republic January, 1978
584. Pituitary control of hepatic steroid metabolism Scientific Conf. on Cytochrome P-450: Structural and Functional Aspects, Eberswalde, German Democratic Republic January, 1978
585. Steroid metabolism in the fetal and perinatal period Fogarty Conference on Neonatal Hepatitis and Biliary Atresia, Bethesda, USA September, 1977
586. Programming and differentiation of rat liver enzymes Meeting of the Journal of Steroid Biochemistry, Paris, France September, 1976
587. Studies on a cytochrome P-450-dependent hydroxylase system active on steroids in Bacillus megaterium III Int. Symposium on Microsomes and Drug Oxidations, Berlin, West Germany September, 1976
588. On the presence of a major protein, prostatic secretion protein or estramustine-binding protein, in the rat ventral prostate and in the human prostate Workshop of the Society of Urologic Oncology and Endocrinology: Steroid Receptors, Metabolism and Prostatic Cancer, Amsterdam, The Netherlands July, 1976
589. Glucocorticoid-receptor interactions in rat liver 568th Meeting of the Biochemical Society in Aberdeen on Steroid Binding and Oligomeric Proteins, Aberdeen, Scotland April, 1976
590. Progestin receptor in endometrial carcinoma Int. Meeting on Progesterone Receptors in Normal and Neoplastic Tissues, Montreal, Canada January, 1976
591. Neonatal androgenic programming of hepatic steroid metabolism in rats Int. Congress of Hormonal Steroids, Mexico September, 1974
592. Causes of differences between germfree and conventional rats in liver microsomal metabolism of steroids III Bile Acid Meeting on Advances in Bile Acid Research, Freiburg i. Br., West Germany September, 1974
593. Sexual Differentiation of Hepatic Steroid Metabolism in the Ra The Journal of Steroid Biochemistry Meeting, Paris, France April, 1974
594. Steroids in meconium and faeces from newborn infants The Royal Society Meeting, London, UK January, 1972
595. The role of the intestinal microflora in steroid metabolism 3rd Int. Congress of Hormonal Steroids, Hamburg, West Germany September, 1970



Site wide Speaking/Presenting-Abstract/Poster at Mtg

Presentation Event Month, Year
Novel roles of ERbeta and LXRbeta in neuronal cortical migration and epithelial proliferation Congress on Steroid Research March, 2011

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.